These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12842346)

  • 1. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66.
    Carcaboso AM; Hernández RM; Igartua M; Gascón AR; Rosas JE; Patarroyo ME; Pedraz JL
    Int J Pharm; 2003 Jul; 260(2):273-82. PubMed ID: 12842346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.
    Mata E; Igartua M; Patarroyo ME; Pedraz JL; Hernández RM
    Eur J Pharm Sci; 2011 Sep; 44(1-2):32-40. PubMed ID: 21699977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.
    Rosas JE; Hernández RM; Gascón AR; Igartua M; Guzman F; Patarroyo ME; Pedraz JL
    Vaccine; 2001 Aug; 19(31):4445-51. PubMed ID: 11483270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles.
    Kumar R; Ledet G; Graves R; Datta D; Robinson S; Bansal GP; Mandal T; Kumar N
    Pharm Res; 2015 Dec; 32(12):3827-36. PubMed ID: 26113235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres.
    Rosas JE; Pedraz JL; Hernández RM; Gascón AR; Igartua M; Guzmán F; Rodríguez R; Cortés J; Patarroyo ME
    Vaccine; 2002 Mar; 20(13-14):1707-10. PubMed ID: 11906756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles.
    Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
    Vaccine; 2004 Mar; 22(11-12):1423-32. PubMed ID: 15063565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant activity of polymer microparticles and Montanide ISA 720 on immune responses to Plasmodium falciparum MSP2 long synthetic peptides in mice.
    Mata E; Carcaboso AM; Hernández RM; Igartua M; Corradin G; Pedraz JL
    Vaccine; 2007 Jan; 25(5):877-85. PubMed ID: 17070628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres.
    Gutierro I; Hernández RM; Igartua M; Gascón AR; Pedraz JL
    Vaccine; 2002 Nov; 21(1-2):67-77. PubMed ID: 12443664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-irradiation effects on biopharmaceutical properties of PLGA microspheres loaded with SPf66 synthetic vaccine.
    Igartua M; Hernández RM; Rosas JE; Patarroyo ME; Pedraz JL
    Eur J Pharm Biopharm; 2008 Jun; 69(2):519-26. PubMed ID: 18280123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen.
    Saini V; Jain V; Sudheesh MS; Jaganathan KS; Murthy PK; Kohli DV
    Int J Pharm; 2011 Apr; 408(1-2):50-7. PubMed ID: 21291968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21.
    Kashala O; Amador R; Valero MV; Moreno A; Barbosa A; Nickel B; Daubenberger CA; Guzman F; Pluschke G; Patarroyo ME
    Vaccine; 2002 May; 20(17-18):2263-77. PubMed ID: 12009282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of reconstituted influenza virus virosomes as an immunopotentiating delivery system for a peptide-based vaccine.
    Pöltl-Frank F; Zurbriggen R; Helg A; Stuart F; Robinson J; Glück R; Pluschke G
    Clin Exp Immunol; 1999 Sep; 117(3):496-503. PubMed ID: 10469053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes.
    Puras G; Salvador A; Igartua M; Hernández RM; Pedraz JL
    Eur J Pharm Sci; 2011 Oct; 44(3):200-6. PubMed ID: 21820509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2.
    Singh M; Carlson JR; Briones M; Ugozzoli M; Kazzaz J; Barackman J; Ott G; O'Hagan D
    Vaccine; 1998 Nov; 16(19):1822-7. PubMed ID: 9795387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T; Goto S; Foster TP
    J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
    Men Y; Gander B; Merkle HP; Corradin G
    Vaccine; 1996 Oct; 14(15):1442-50. PubMed ID: 8994320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing immunogenicity and reducing dose of microparticulated synthetic vaccines: single intradermal administration.
    Carcaboso AM; Hernández RM; Igartua M; Rosas JE; Patarroyo ME; Pedraz JL
    Pharm Res; 2004 Jan; 21(1):121-6. PubMed ID: 14984266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the adjuvanticity of two different delivery systems on the induction of humoral and cellular responses to synthetic peptides.
    Mata E; Igartua M; Hernández RM; Rosas JE; Patarroyo ME; Pedraz JL
    Drug Deliv; 2010; 17(7):490-9. PubMed ID: 20500129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.